Randomised Arthroplasty Infection Worldwide Multidomain Adaptive Platform (ROADMAP) Trial (ROADMAP)
The RandOmised Arthroplasty Infection worlDwide Multidomain Adaptive Platform (ROADMAP) Trial
Sponsor: Aotearoa Clinical Trials
Listed as NCT06771050, this PHASE4 trial focuses on Large Joint Prosthetic Joint Infections and Prosthetic Joint Infections of Hip and remains actively recruiting participants. Sponsored by Aotearoa Clinical Trials, it has been updated 3 times since 2025, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
3 versions recorded-
Jun 2025 — Present [monthly]
Not Yet Recruiting PHASE4
-
Apr 2025 — Jun 2025 [monthly]
Not Yet Recruiting PHASE4
-
Feb 2025 — Apr 2025 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Aotearoa Clinical Trials
- Exeter Orthopaedic Trial unit
- Hunter Medical Research Institute (HMRI)
- Michael Garron Hospital
- The Peter Doherty Institute for Infection and Immunity
- The University of Western Australia
- University of Melbourne
- University of Newcastle, Australia
- University of Sydney
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Adelaide, Australia , Bedford Park, Australia , Birtinya, Australia , Blacktown, Australia , Box Hill, Australia , Camperdown, Australia , Chermside, Australia , Dandenong, Australia , Douglas, Australia , Epping, Australia and 19 more locations